Assertio focuses its pharmaceutical commercialization efforts primarily across three to four core therapeutic categories: neurology, pain management, inflammation, and specialty hospital care, alongside targeted oncology supportive care. By concentrating its portfolio on these specialized medical segments, the company aims to address complex chronic conditions and provide value-driven treatment options supported by its digital promotion and commercial infrastructure.